Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers digital cognitive assessments, including the CANTAB cognitive assessment battery, which measures cognitive function correlated to neural networks; a voice analysis platform, an automated speech assessment tool that provides real-time scoring for cognitive performance; and high frequency testing, which detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), which collect neurocognitive data in a data capture system; the automated quality assurance (AQUA) solution, which analyzes the audio during the administration of central nervous system (CNS) clinical scales to detect deviations in administration and scoring; and Clinpal, a decentralized clinical trials platform. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.